Abbott Laboratories ABT
Set alert
110.11 USD -0.05 -0.05%
As of Nov 3, 11:24 AM ET
109.09 Day range 110.60
81.97 52-week range 132.03
- YTD
- -12.12%
- 1 year
- -11.09%
- Open
- 109.36
- Prev close
- 110.16
- Mkt cap
- 190.52B
- Vol
- 1.88M
- Avg vol
- 8.77M
- EPS
- 2.69
- P/E
- 40.93
- Div yield
- 2.41%
More statistics
- Low
- 109.09
- High
- 110.60
- Forward P/E
- 18.57
- Beta
- 0.54
- Short ratio
- 1.84
- Inst. own
- 81.92%
- Dividend
- 2.52
- Ex-div date
- Oct 14, 2026
- Earnings
- Jan 28, 2027
- 50-d avg
- 104.34
- 200-d avg
- 101.69
- 1y target
- 118.52
6M chart
Events in this range
- Jul 15, 2026Dividend: 0.63
- Jul 16, 2026Earnings: 1.31; estimate 1.28; surprise 2.34%
- Oct 15, 2026Dividend: 0.63
- Oct 21, 2026Earnings: 1.42; estimate 1.42; surprise 0%
- Oct 22, 2026Rating: JP Morgan · Overweight → Overweight
- Oct 22, 2026Rating: Wells Fargo · Overweight → Overweight
- Oct 22, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 22, 2026Rating: Citigroup · Buy → Buy
- Oct 23, 2026Rating: Wells Fargo · Overweight → Overweight
- Oct 27, 2026Downgrade: Argus Research · Buy → Hold
Signals (21)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 29, 2026 | 5 days ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| RSI: Oversold | Sep 30, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 27, 2026 | 2 months ago |
| RSI: Overbought | Aug 18, 2026 | 2 months ago |
| RSI: Overbought | Aug 11, 2026 | 2 months ago |
| RSI: Overbought | Jul 28, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 17, 2026 | 3 months ago |
| SMA: Bullish | Jul 16, 2026 | 3 months ago |
| SMA: Bullish | Jul 15, 2026 | 3 months ago |
| SMA: Bearish | Jul 14, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| SMA: Bullish | Jun 23, 2026 | 4 months ago |
Newest 20 of 21.
Analyst view
Consensus: buy
Buy
Price target (mean) 118.52 +7.6% upside
Now 110.11
- Target (low)
- 100.00
- Target (mean)
- 118.52
- Target (high)
- 130.00
Ratings (0m) 28 23 buy · 5 hold · 0 sell
- Strong buy5
- Buy18
- Hold5
- Sell0
- Strong sell0
Recommendation trend
- This month 28
- 1 month ago 27
- 2 months ago 27
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.64 | 1.63 – 1.64 | 1.50 | +9.2% | 13.23B | +15.4% | 23 |
| Next quarter | 1.23 | 1.20 – 1.28 | 1.15 | +7.0% | 12.58B | +12.7% | 18 |
| Current year | 5.52 | 5.49 – 5.54 | 5.15 | +7.2% | 49.96B | +12.7% | 27 |
| Next year | 5.94 | 5.89 – 6.08 | 5.52 | +7.6% | 53.53B | +7.1% | 27 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2026 | Argus Research | Downgrade | Buy | Hold |
| Oct 23, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 22, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 22, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 22, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 22, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 22, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 22, 2026 | Baird | Maintained | Outperform | Outperform |
| Oct 22, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 16, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Oct 7, 2026 | Barclays | Initiated | — | Overweight |
| Oct 2, 2026 | Rothschild & Co | Upgrade | Neutral | Buy |
| Sep 8, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Aug 25, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 21, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 14, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 13, 2026 | Wolfe Research | Upgrade | Peer Perform | Outperform |
| Jul 28, 2026 | UBS | Maintained | Buy | Buy |
| Jul 17, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 17, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Jul 17, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 17, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 17, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Jul 17, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 17, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| Jul 17, 2026 | BTIG | Maintained | Buy | Buy |
| Jul 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 1, 2026 | Baird | Initiated | — | Outperform |
| Jun 22, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| May 31, 2026 | Goldman Sachs | Maintained | Buy | Buy |